Breastfeeding women finally included in TB drug research
NCT ID NCT07069582
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how five common tuberculosis drugs move into breast milk after a single dose. Sixty healthy breastfeeding women in Indonesia will each receive one drug, and researchers will measure drug levels in their blood and milk. The goal is to gather safety data so that breastfeeding women can be included in future TB prevention trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rifampicin, isoniazid, levofloxacin, rifapentine, and bedaquiline
- What this could lead to
- If successful, this study could help include breastfeeding women in future TB prevention trials, ensuring safer dosing guidelines for mothers and infants.
- What could go wrong
- This is an early-phase, single-dose study in healthy volunteers, not patients. Results may not apply to women with TB or to repeated dosing, and drug levels in milk may vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREASTFEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitas Padjadjaran, Klinik Penelitian Tuberculosis (TB Research Clinic)
Bandung, West Java, 40161, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tongue-Tie and breastfeeding: a closer look at the first six months
- Can eye movements reveal the Brain's visual priorities?
- Could calming Moms-to-Be boost baby brain health?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- Boosting breastfeeding confidence in teen moms: a new approach put to the test
- First look: can a new drug candidate pass early safety tests in humans?